Serum Adiponectin Predicts COVID-19 Severity

被引:2
|
作者
Pavel, Vlad [1 ]
Raeth, Ulrich [1 ]
Schmid, Stephan [1 ]
Krautbauer, Sabrina [2 ]
Keller, Dennis [1 ]
Amend, Pablo [1 ]
Mueller, Martina [1 ]
Mester, Patricia [1 ]
Buechler, Christa [1 ]
机构
[1] Univ Hosp Regensburg, Dept Internal Med Gastroenterol Hepatol Endocrinol, D-93053 Regensburg, Germany
[2] Univ Hosp Regensburg, Inst Clin Chem & Lab Med, D-93053 Regensburg, Germany
关键词
adiponectin; disease severity; C-reactive protein; intensive care; bacterial superinfection; COVID-19; ADIPOSE-TISSUE; EXPRESSION; MORTALITY; MARKERS; OBESITY; SEPSIS;
D O I
10.3390/biomedicines12051043
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Adiponectin is primarily known for its protective role in metabolic diseases, and it also possesses immunoregulatory properties. Elevated levels of adiponectin have been observed in various inflammatory diseases. However, studies investigating adiponectin levels in the serum of COVID-19 patients have yielded conflicting results. This study aimed to assess serum adiponectin levels in 26 healthy controls, as well as in 64 patients with moderate and 60 patients with severe COVID-19, to determine a potential association between serum adiponectin and the severity of COVID-19. Serum adiponectin levels in severe COVID-19 patients were significantly lower than in those with moderate disease and healthy controls, who exhibited similar serum adiponectin levels. Among patients with moderate disease, positive correlations were observed between serum adiponectin and C-reactive protein levels. Of note, serum adiponectin levels of severe COVID-19 cases were comparable between patients with and without dialysis or vasopressor therapy. Superinfection with bacteria did not exert a notable influence on serum adiponectin levels in patients with severe disease. Patients who were diagnosed with severe COVID-19 and vancomycin-resistant enterococci bacteremia showed a significant reduction in their serum adiponectin levels. An analysis conducted on the entire cohort, including both moderate and severe COVID-19 patients, showed that individuals who did not survive had lower serum adiponectin levels when compared to those who survived. In summary, this study highlights a decrease in serum adiponectin levels in severe COVID-19 cases, indicating the potential utility of adiponectin as an additional biomarker for monitoring disease severity in COVID-19 or critical illnesses in general.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Bulk IgG glycosylation predicts COVID-19 severity and vaccine antibody response
    Ash, Michelle K.
    Bhimalli, Pavan P.
    Cho, Byoung-Kyu
    Mattamana, Basil Baby
    Gambut, Stephanie
    Tarhoni, Imad
    Fhied, Cristina L.
    Reyes, Anjelica F.
    Welninski, Samantha J.
    Arivalagan, Jaison
    Negrao, Fernanda
    Goel, Renu
    Beck, Todd L.
    Hope, Thomas J.
    Sha, Beverly E.
    Goo, Young Ah
    Al-Harthi, Lena
    Mamede, Joao I.
    Borgia, Jeffrey A.
    Kelleher, Neil L.
    Schneider, Jeffrey R.
    CELL REPORTS, 2022, 41 (11):
  • [32] BIOLOGICAL AGING PREDICTS VULNERABILITY TO COVID-19 SEVERITY IN UK BIOBANK PARTICIPANTS
    Kuo, Chia-Ling
    Pilling, Luke
    Atkins, Janice
    Masoli, Jane
    Delgado, Joao
    Kuchel, George
    Melzer, David
    Levine, Morgan
    INNOVATION IN AGING, 2021, 5 : 331 - 331
  • [33] Detection of the Serum Cytokines Predicts COVID-19 Pathogenesis in Egyptian Patients
    Mobarak, Lamiaa
    Shemis, Mohamed
    Abdellatif, Raghda Samir
    Fouad, Amina
    Elberry, Mostafa H.
    Dawood, Reham M.
    VIRAL IMMUNOLOGY, 2022, 35 (07) : 503 - 508
  • [34] Serum calprotectin can indicate current and future severity of COVID-19
    Shokri-Afra, Hajar
    Moradi, Mona
    Musavi, Hadis
    Moradi-Sardareh, Hemen
    Poodeh, Bahman Moradi
    Veisari, Arash Kazemi
    Oladi, Ziaeddin
    Ebrahimi, Mahboobe
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2023, 37 (01)
  • [35] Serum biomarker panel for disease severity and prognosis in patients with COVID-19
    Li, Jing
    Tang, Mingyang
    Liu, Didi
    Xie, Zongyu
    Wang, Fengchao
    Yang, Yanqing
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2023, 37 (02)
  • [36] The predictive value of serum level of cystatin C for COVID-19 severity
    Lin, Luanfeng
    Chen, Xiaoling
    Chen, Junnian
    Pan, Xiaobin
    Xia, Pincang
    Lin, Hailong
    Du, Houwei
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [37] Correlation of Serum Calcium with Severity and Outcomes in Patients of COVID-19 Pneumonia
    Fatima, Jalees
    Shukla, Vaibhav
    Siddiqi, Zeba
    Kumar, Devendra
    Mateen, Saboor
    Gupta, Akhilesh Bandhu
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2024, 13 (04) : 1421 - 1427
  • [38] Increased Serum Levels of Hepcidin and Ferritin Are Associated with Severity of COVID-19
    Zhou, Cuixing
    Chen, Yimeng
    Ji, Yun
    He, Xiaozhou
    Xue, Dong
    MEDICAL SCIENCE MONITOR, 2020, 26
  • [39] Relationship between serum osteopontin levels and the severity of COVID-19 infection
    Varim, Ceyhun
    Demirci, Taner
    Cengiz, Hasret
    Hacibekiroglu, Ilhan
    Tuncer, Fatima Betul
    Cokluk, Erdem
    Toptan, Hande
    Karabay, Oguz
    Yildirim, Ilhan
    WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (7-8) : 298 - 302
  • [40] Mapping the Serum Proteome of COVID-19 Patients; Guidance for Severity Assessment
    Nunez, Estefania
    Orera, Irene
    Carmona-Rodriguez, Lorena
    Ramon Pano, Jose
    Vazquez, Jesus
    Corrales, Fernando J.
    BIOMEDICINES, 2022, 10 (07)